In response to the urgent need to control the spread of TB, the U.S. Congress passed the Reauthorization Act supporting a substantial increase in USG funding for TB treatment and control over a five-year period. The Reauthorization Act requests the development of a USG Global Tuberculosis Strategy.
Favorite
International Agencies
2010
This manual provides basic information on TB testing, and lists key points in evaluating, treating, and monitoring children and adolescents who have latent TB infection.
Favorite
2009
This pocket-size drug treatment card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in children, including dosages, daily and intermittent regimens, side effects, treatment information and visual depictions of first-line medications.
Favorite
2009
This training course uses a variety of methods of instruction to help health workers develop specific skills necessary to diagnose persons with TB and manage treatment for their patients. The training course consists of 10 modules titled: 'A: Introduction', 'B: Detect Cases of TB', 'C: Treat TB Patients', 'D: Inform Patients About TB', 'E: Identify and Supervise Community TB Treatment Supporters', 'F: Manage Drugs and Supplies for TB', 'G: Ensure Continuation of TB Treatment', 'H: Monitor TB Case Detection and Treatment', 'I: TB Infection Control in Your Health Facility', and 'J: Field Exercise - Observe TB Management', and 'K: Management of Tuberculosis - Reference booklet'
Favorite
Infection Control and Occupational Health Workers
2009
This pocket-size drug treatment information card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in adults, including dosages, daily and intermittent regimens, side effects, treatment information, and visual depictions of first-line medications.
Favorite
2009
This report was produced by a Federal TB task force that was reconvened by CDC in November 2006. The task force drafted an updated action plan to address the issue of multidrug-resistant TB (MDR TB) and extensively drug-resistant TB (XDR TB). Task force members were charged with articulating the most pressing problems, identifying barriers to improvement, and recommending specific action steps to improve prevention and control of XDR TB in their respective areas...
Favorite
2009
This report describes a study that determined whether differences in national trends in tuberculosis (TB) incidence are attributable to the variable success of control programs or to biological, social, and economic factors. Trends in case notifications were used as a measure of trends in incidence in 135 countries from 1997-2006, and regression analysis was used to explore the associations between these trends and 32 measures covering aspects of development, the economy, the population, behavioral and biological risk factors, health services, and TB control...
Favorite
2009
This book provides vital information about tuberculosis, including drug-resistant strains of the disease. Coverage includes which patient populations face an elevated risk of infection, as well as which therapies are appropriate and how to correctly monitor ongoing treatment so that patients are cured...
Favorite
Health Educators/Communicators
2009
The purpose of this document is to examine the different parameters necessary for an effective upper-room ultraviolet germicidal irradiation (UVGI) system and to provide guidelines to healthcare managers, facility designers, engineers, and industrial hygienists on the parameters necessary to install and maintain an effective upper-room UVGI system.
Favorite
Infection Control and Occupational Health Workers
2009
This book takes a historical look at the power of posters to persuade people to change their behaviour. It charts decades of changing health priorities, advertising trends and government regulations, inviting the reader to reflect on how public health campaigns have evolved, and how they could be improved...
Favorite
Health Educators/Communicators
2009
WHO's report on Global TB Control compiles data from over 200 countries and territories each year, monitoring the scale and direction of TB epidemics, implementation and impact of the Stop TB Strategy, and progress towards the Millennium Development Goals.
Order online: http://apps.who.int/bookorders/anglais/detart1...
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2009
This report details the activities of the International Union Against Tuberculosis and Lung Disease (The Union) for the year 2008.
Favorite
International Agencies
Policy Makers
2009
This publication by the Treatment Action Group (TAG) and the International Community of Women Living with HIV/AIDS (ICW) provides lessons learned from two years of capacity building for HIV treatment activists. Policy makers, activists, and donors can integrate these lessons learned into their tuberculosis (TB) and TB/HIV activities advocacy work.
Favorite
Community Based Organizations
Community Leaders
Policy Makers
2009
This resource provides a patient’s perspective by presenting one patient’s story of being on home isolation.
Favorite
Persons With LTBI
2009
This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.
Favorite
International Agencies
Policy Makers
2009
This report on the uses of nucleic acid amplification (NAA) tests for diagnosis of TB is based on contributions of an expert panel of consultants convened by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL). The report presents the background for the study; general considerations, such as optimum patient care and public health, the value of NAA testing for clinicians and TB control officials, limitations of the tests, costs and funding issues, and turnaround time; research needs; available information on molecular drug susceptibility tests; the general recommendations of the panel; the communication plan for the new recommendations; and recommendations to the Advisory Council for the Elimination of TB (ACET), CDC, and the Division of TB Elimination (DTBE)...
Favorite
2009
This report presents results from an expert panel convened by CDC to examine the current status of rapid drug-resistance (DR) testing in the United States; to research published evidence and current guidelines; and to provide guidance and make recommendations to CDC for developing a system to provide access to rapid drug-susceptibility testing to all TB control programs in the United States...
Favorite
2009
This report provides World Health Organization (WHO) member states with guidance on preventing TB transmission in healthcare facilities, congregate settings, and households. It focuses on what to do and how to prioritize TB infection control at national levels and includes recommendations for national managerial activities...
Favorite
2009
This report describes the investigation by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), which initially identified five confirmed cases of multidrug-resistant tuberculosis (MDR TB) in two distinct clusters, characterized by two distinct geographic locations, genotypes, and drug-susceptibility patterns in the Federated States of Micronesia...
Favorite
2009
This report describes the investigation of a genotype cluster of eight tuberculosis cases in US born patients in the Detroit metropolitan area. The investigation was done by the Detroit Department of Health and Wellness Promotion, the Michigan Department of Community Health, and the Centers for Disease Control and Prevention...
Favorite
2009
